Evolving treatment for prematurity-associated lung disease.
| Autor: | Course CW; Department of Child Health, School of Medicine, Cardiff University, Cardiff, UK., Kotecha SJ; Department of Child Health, School of Medicine, Cardiff University, Cardiff, UK., Kotecha S; Department of Child Health, School of Medicine, Cardiff University, Cardiff, UK. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Translational pediatrics [Transl Pediatr] 2024 Jan 29; Vol. 13 (1), pp. 1-5. Date of Electronic Publication: 2024 Jan 15. |
| DOI: | 10.21037/tp-23-505 |
| Abstrakt: | Competing Interests: Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tp.amegroups.com/article/view/10.21037/tp-23-505/coif). S.K. has received research grant funding from the Medical Research Council and GSK for the current work, consulted for Aspire Pharma, and received grant funding from the Moulton Foundation and Aspire Pharma outside this work. The other authors have no conflicts of interest to declare. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|